Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ITI-3000 |
| Trade Name | |
| Synonyms | ITI 3000|ITI3000 |
| Drug Descriptions |
ITI-3000 is a cancer vaccine comprised of a Merkel cell polyomavirus large T antigen (MCPyV-LT) linked to lysosomal-associated membrane protein 1 (LAMP1), which may lead to an enhanced antitumor immune response and inhibition of tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2052). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ITI-3000 | ITI-3000 | 0 | 1 |